NASDAQ · Software - Application · USD
Health In Tech, Inc. (HIT) Stock Analysis
Health In Tech, Inc. (HIT) is a Software - Application stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
HIT Key Statistics
As of Oct 21, 2026Trading
- Open
- $0.55
- Previous Close
- $0.56
- Day's Range
- 0.50–0.61
- 52-Week Range
- 0.50–3.12
- Volume
- 80.25K
Valuation
- Market Cap
- $39.19M
- P/E Ratio
- unprofitable
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.19
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −0.07
Financials (FY)
- Revenue (FY)
- $33.33M+70.99%
- Net Income (FY)
- $1.28M+90.74%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −12.03%
- Shares Outstanding
- 53.60M
- 1-Year Return
- −80.00%
Dividend and dates
- Earnings Date
- November 9, 2026estimated
- Avg Volume
- 172.59K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, HIT closed at $0.60, −80.00% over 1 year.
Health In Tech, Inc. (HIT) has a market capitalization of $39.19M.
In fiscal 2025, HIT reported revenue of $33.33M.
HIT Stock Return by Calendar Year
Health In Tech, Inc. (HIT) return since Dec 2024: what $10,000 became
- 1 year
- $10,000 $2,000
- −80.00%
- Since Dec 2024
- $10,000 $1,177
- −88.23%
If you had invested $10,000 in Health In Tech, Inc. (HIT) at the close on December 23, 2024, the earliest close on record here, it would have been worth $1,177 at the close on October 21, 2026: −88.23% in total, −69.02% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −62.26% |
| 2025 | −70.31% |
| 2024 (partial year) | +5.00% |
As of October 21, 2026.
HIT Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $33.33M | $1.28M | 3.8% |
| 2024 | $19.49M | $670.48K | 3.4% |
| 2023 | $19.15M | $2.48M | 12.9% |
| 2022 | $5.77M | $79.74K | 1.4% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $33.33M | $20.94M | $1.53M | $1.28M | 3.8% |
| 2024 | $19.49M | $15.44M | $989.90K | $670.48K | 3.4% |
| 2023 | $19.15M | $16.85M | $3.38M | $2.48M | 12.9% |
| 2022 | $5.77M | $5.44M | $205.58K | $79.74K | 1.4% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
HIT Valuation vs Software - Application Median
Median of 240 stocks| Metric | HIT | Software - Application median | vs median |
|---|---|---|---|
| P/S ratio | 1.19 | 2.83 | 58% below |
| Profit margin | −12.03% | 0.82% | 12.8 pts below |
Medians across 240 Software - Application stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Health In Tech to Host Annual Meeting of Stockholders
YahooHealth In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement
YahooHealth In Tech Rolls Out AI-Powered HitRix
BenzingaHealth In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference
YahooHealth In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance
YahooHealth In Tech Rolls Out AI-Powered Platform HitRix; Expects FY26 Revenue To Be ~$33M
Benzinga
All 14 articles ↓Show fewer ↑
Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026
YahooHealth In Tech Files Prospectus For Resale Of Up To 29,532,889 Shares By Yorkville Under $20M Standby Equity Purchase Agreement
BenzingaMaxim Group Maintains Buy on Health In Tech, Lowers Price Target to $3
BenzingaHealth In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript
SeekingAlphaHealth In Tech, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaHealth In Tech Q2 2026 Earnings Call: Complete Transcript
BenzingaHealth In Tech Affirms FY2026 Sales Guidance of $45.000M-$50.000M vs $46.813M Est
BenzingaHealth In Tech Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $8.057M Beat $7.547M Estimate
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Software - Application Stocks
SAP SE
$268.62B
SHOPShopify Inc.
$226.17B
CRMSalesforce, Inc.
$198.98B
NOWServiceNow, Inc.
$158.30B
UBERUber Technologies, Inc.
$138.12B
ADPAutomatic Data Processing, Inc.
$116.70B
Popular Technology Stocks
NVIDIA Corporation
$5.36T
AAPLApple Inc.
$5.02T
MSFTMicrosoft Corporation
$3.96T
TSMTaiwan Semiconductor Manufacturing Company Limited
$2.24T
AVGOBroadcom Inc.
$1.61T









